<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01331954</url>
  </required_header>
  <id_info>
    <org_study_id>HIFU/BG/FA/Jan2011</org_study_id>
    <nct_id>NCT01331954</nct_id>
  </id_info>
  <brief_title>Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)</brief_title>
  <official_title>Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU): a Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theraclion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theraclion</source>
  <brief_summary>
    <textblock>
      Demonstrate the efficacy of High Intensity Focused Ultrasound in the treatment of the breast
      fibroadenoma.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2011</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of breast fibroadenoma volume at ultrasonography</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Breast Fibroadenoma</condition>
  <arm_group>
    <arm_group_label>HIFU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasonic ablation device</intervention_name>
    <description>One or two HIFU procedures</description>
    <arm_group_label>HIFU</arm_group_label>
    <other_name>TH-One</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  One breast fibroadenoma with diagnosis based on:

               -  Clinical examination

               -  Ultrasound image

               -  For women older than 35 years: mammogram with BI-RADS score &lt; 3

               -  Histologic confirmation by two independent readers

          -  Fibroadenoma size between 1 cm and 3 cm at its largest dimension (measured by
             ultrasound)

        Exclusion Criteria:

          -  Patient pregnant or lactating

          -  Bi-RADS score &gt; 2 at the mammogram, or microcalcifications within the lesion.

          -  History of breast cancer or history of laser or radiation therapy to the target breast

          -  Breast implants

          -  Breast cyst

          -  Fibroadenoma not clearly visible on the ultrasound images (in B mode)

          -  Patient participating in other trials using drugs or devices
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roussanka Kovatcheva, M</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Endocrinology (USBALE) &quot;Acad. Ivan Penchev&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Endocrinology (USBALE) &quot;Acad. Ivan Penchev&quot;</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bulgaria</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2011</study_first_submitted>
  <study_first_submitted_qc>April 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2011</study_first_posted>
  <last_update_submitted>May 25, 2018</last_update_submitted>
  <last_update_submitted_qc>May 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibroadenoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

